The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic

$ 31.99

4.6 (752) In stock

Non-alcoholic fatty liver disease-related hepatocellular carcinoma

Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge

Enhancing Hepatic MBOAT7 Expression Does Not Improve Nonalcoholic Steatohepatitis in Mice

Genetic and metabolic factors: the perfect combination to treat metabolic associated fatty liver disease

Genetic and metabolic aspects of non-alcoholic fatty liver disease (NAFLD) pathogenicity, Egyptian Journal of Medical Human Genetics

PDF] A Protein‐Truncating HSD17B13 Variant and Protection from Chronic Liver Disease

Emerging risk factors for nonalcoholic fatty liver disease associated hepatocellular carcinoma

PDF) MBOAT7 rs641738 (C>T) is associated with NAFLD progression in men and decreased ASCVD risk in elder Chinese population

Frontiers MBOAT7 rs641738 (C>T) is associated with NAFLD progression in men and decreased ASCVD risk in elder Chinese population

Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers

LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover

The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent - ScienceDirect

Frontiers MBOAT7 rs641738 (C>T) is associated with NAFLD progression in men and decreased ASCVD risk in elder Chinese population